THE MCCULLOUGH REPORT

Bio-Pharmaceutical complex wages war against respiratory syncytial virus

01.09.2024 - By Dr. Peter McCulloughPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The McCullough Report with Dr. Peter McCullough – As ambient aerosolized RSV virions are present in hospitals, clinics, and homes, the monoclonal antibody may backfire and enable the inhaled virion to gain access to the bronchial epithelial lining and cause worse bronchiolitis than the baby would have with their own developing natural immunity. This would explain why the efficacy for RSV hospitalization was NOT compelling from the two RCTs of Nirsevimab...

More episodes from THE MCCULLOUGH REPORT